Zeier M
Department of Medicine, Division of Nephrology, University of Heidelberg, Germany.
Horm Res. 2002;58 Suppl 3:30-4. doi: 10.1159/000066486.
The mortality rate of dialysis patients is still considerably high. Beside the traditional risk factors, specific uremia-related risk factors are identified. Among them, hypoalbuminemia and malnutrition have a strong association to mortality in chronic dialysis patients. Various studies document a strong relation between reduced calorie and protein uptake and mortality in uremic patients. Several factors responsible for malnutrition in dialysis patients have been identified. These factors may be dialysis-associated, due to intercurrent illnesses or are associated with uremic complications (e.g. hyperparathyroidism, anemia, acidosis, etc.). Malnutrition is treatable and can be avoided by several means. Beside the increase in the dose of dialysis and adequate protein and calorie intake, intradialytic nutrition is an additional choice. The combination with specific drugs (e.g. growth hormone) may potentiate the success of the modified treatment modalities, particularly in patients who need nutritional support during an intercurrent illness. Further studies are required to measure the impact of for example growth hormone supplementation on mortality rate and quality of life in malnourished patients on chronic dialysis.
透析患者的死亡率仍然相当高。除了传统的风险因素外,还确定了与尿毒症相关的特定风险因素。其中,低白蛋白血症和营养不良与慢性透析患者的死亡率密切相关。各种研究表明,尿毒症患者热量和蛋白质摄入量减少与死亡率之间存在密切关系。已经确定了导致透析患者营养不良的几个因素。这些因素可能与透析相关,也可能是由于并发疾病或与尿毒症并发症(如甲状旁腺功能亢进、贫血、酸中毒等)有关。营养不良是可以治疗的,并且可以通过多种方法避免。除了增加透析剂量以及保证充足的蛋白质和热量摄入外,透析期间营养补充也是一种选择。与特定药物(如生长激素)联合使用可能会增强改良治疗方式的效果,特别是对于在并发疾病期间需要营养支持的患者。需要进一步研究来衡量例如补充生长激素对慢性透析营养不良患者死亡率和生活质量的影响。